The new GLA-3M-052-LS+OVA vaccine can be delivered as a nasal spray. Three doses protected mice from infection from SARS-CoV-2 and other coronaviruses for three months, and reduced the viral load in ...

In an early animal test, a new nasal-spray vaccine has shown promise against a variety of germs and a common allergen, ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once.

A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data licensing agreement to access Adaptive’s proprietary TCR-antigen datasets for research ...

Adaptive Biotechnologies (“we” or “our”) is a commercial-stage biotechnology company focused on harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment ...

Stanford Medicine researchers have developed an intranasal liposomal vaccine that protected mice against SARS-CoV-2, ...

In the realm of medical advancements, a universal vaccine that can protect against any pathogen has long been a Holy ...

A new Stanford study marks a big step forward in the creation of a new kind of vaccine that offers protection against a range of infections at once. Traditionally, vaccines protect against one ...

clonoSEQ is the only DLBCL MRD assay available for clinical use and covered by Medicare SEATTLE, March 11, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial ...

Cancer immunotherapies, including cancer vaccines, harness and amplify the immune system’s natural ability to detect and attack cancer cells. In this illustration, immune T cells (pink) attach to a ...

The MarketWatch News Department was not involved in the creation of this content. A target discovery agreement to identify disease-specific T-cell receptors (TCRs) in rheumatoid arthritis A data ...